Sage-Biogen drug improves symptoms in postpartum depression study
Go back to Sage-Biogen drug improves symptoms in postpartum depression study| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 209.48 -1.17 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $210.65 | 52 Week High | $333.65 | |||
| Open | $210.01 | 52 Week Low | $223.02 | |||
| Day High | $210.79 | P/E | 26.82 | |||
| Day Low | $208.22 | EPS | $7.81 | |||
| Volume | 185,671 | |||||
| Sagebrush Gold Ltd. (NASDAQ: SAGE) | Delayed: 8.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.68 | 52 Week High | $62.64 | |||
| Open | $8.68 | 52 Week Low | $26.28 | |||
| Day High | $8.68 | P/E | N/A | |||
| Day Low | $8.68 | EPS | $-0.94 | |||
| Volume | 100,963 | |||||
